South African rugby franchise the Hollywoodbets Sharks have appointed MedWave as the union’s official photobiomodulation and recovery technology supplier, bringing red and near-infrared light therapy into the team’s high performance and medical environment.
Under the partnership, MedWave has supplied three Neuro-100s photobiomodulation and recovery technology units to the franchise, which will be used by Sharks players across the United Rugby Championship, European competition and the Currie Cup. MedWave is responsible for installation, staff training, servicing and maintenance of the equipment throughout the season.
Photobiomodulation (PBM), commonly known as red light therapy, is a non-thermal, non-invasive technology. It delivers specific red and near-infrared wavelengths of light to light-sensitive structures within tissues, supporting cellular energy production. Researchers continue to study how PBM interacts with the body’s natural recovery processes after physical activity, and the technology is increasingly used in elite sport.
The partnership also includes a dedicated player welfare education and demonstration session, facilitated by the Sharks’ Head of Medical with MedWave’s specialists, covering how recovery technology can support player welfare, rehabilitation and return-to-play programmes.
Deane Macquet, Lead Physiotherapist at the Sharks, said the partnership is intended to keep the union at the leading edge of sports recovery, with the wellbeing of its players at heart.
“Photobiomodulation can play a meaningful role in how our players recover. Professional rugby players put their bodies through extremes week in, and week out. Recovering properly between training and matches matters for performance on the weekend, and a well-recovered, healthy athlete also has a longer, more sustainable career.
“We thank MedWave for giving our players access to world-class photobiomodulation therapy.”
Dr Margo de Kooker, medical doctor, physiologist and Chief Medical Officer of MedWave, said the partnership would be guided by clinical rigour rather than hype.
“There is no single ‘miracle protocol’. Every player using this modality has a unique physiology, workload and recovery profile. Professional rugby demands sound clinical judgement, and we will work alongside the Sharks’ medical team, asking the right questions and responding to clinical and player feedback,” she said.
Davide Duranti, CEO of MedWave, said: “The future of performance and healthcare will increasingly focus on prevention, recovery and long-term wellbeing. At MedWave, we believe innovation must be matched by clinical oversight, rigorous quality standards and evidence-based application. Partnering with the Sharks allows us to demonstrate this at the highest level of South African rugby. This is about precisely calibrated technology, supported by professionals who understand recovery.
MedWave will feature across Sharks home matches, the Sharks’ digital matchday programme and the official supplier section of the Sharks website, with behind-the-scenes content from the Sharks’ in-house team to follow during the season.